Innoviva Inc - Company Profile
Powered by 
All the data and insights you need on Innoviva Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Innoviva Inc Strategy Report
- Understand Innoviva Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Innoviva Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Innoviva Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 29 Oct 2021 | Lorem |
| Ionis’ Phase I IONIS-TMPRSS6-LRx is strong competitor to Protagonist’s and La Jolla’s Phase II hepcidin drugs in beta thalassemia due to a longer duration of effect, experts say | 29 Mar 2019 | Mariana Lenharo |
| Antibiotic sales struggling to reach market projections to see reimbursement woes read through to upcoming launches, experts say | 25 Mar 2019 | Manasi Vaidya |
| Protagonist’s PTG-300, La Jolla’s LJPC-401 early data suggests the hepcidin drugs have potential to reduce transfusion needs and treat iron overload in beta thalassemia, experts say | 22 Mar 2019 | Mariana Lenharo |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer